United Therapeutics

Business Services · Maryland, United States · 1,168 Employees

View Company Info for Free

About

Headquarters

1000 Spring St, Silver Spring, Maryland, 20910,...

Phone Number

(301) 608-9292

Website

www.unither.com

Revenue

$2.8 Billion

Stock Symbol

UTHR

Industry

Business Services General

Business Services

Most Recent Scoops

Jan 3 2025

Open Position

United Therapeutics is currently seeking a Associate Director, Organizational Resilience & Project Management. (California, Maryland, United States)

Dec 18 2024

Project

United Therapeutics is selective in its approach to opportunities, focusing on those that fit well with existing strengths in orphan drugs, cardiopulmonary diseases, and oncology products complementing Unitux. The company leverages its manufacturing capabilities and clinical trial management expertise when considering opportunities.

See all scoops

Highlights

$54M

Total Funding Amount

$54M

Most Recent Funding Amount

Number of Funding Rounds

View details

Who is United Therapeutics

United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases worldwide. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.Explore more

Is this data correct?

View contact profiles from United Therapeutics

Popular Searchesunited therapeutics CorpUnited TherapeuticsUnither Biotech IncUnither Pharma IncUnither PharmaceuticalsSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: UTHRShow more

United Therapeutics Org Chart

Phone

James Edgemond

Chief Financial Officer & Treasurer

Phone

Michael Benkowitz

President & Chief Operating Officer

Phone

Is United Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Check if United Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Earning: See what the market has to say on United Therapeutics recently announced quarterly report

Check out if United Therapeutics is spiking on competitors!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Congratulate Masked Content for being promoted to Masked Content at United Therapeutics

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when United Therapeutics launches new products

Click to see if United Therapeutics had a recent Job posting/layoffs

United Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Funding: Get notified immidiatlly once United Therapeutics has new funding data

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 3 more new buyers

Compare Similar Companies to United Therapeutics

Compare insights from companies similar to United Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

United Therapeutics

$2.8B

1.2K

Jazz Pharmaceuticals

$3.9B

2.8K

BioMarin

$2.8B

3.4K

Neurocrine Biosciences

$2.2B

1.7K

Exelixis

$2.1B

1.3K

PTC Therapeutics

$900.5M

988

EMD Serono

$758.5M

2.1K

View Email Formats for United Therapeutics

United Therapeutics financials insights

Gather financial insights about United Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Graph showing recent funding, most recent acquisition, and main investor information for United Therapeutics.

See All Financials Insights

United Therapeutics Employee Growth Rate

Graph showing projected employee growth data for United Therapeutics

View United Therapeutics’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

United Therapeutics Tech Stack

A closer look at the technologies used by United Therapeutics

PHP

See more technologies

Most Recent Scoops

Jan 3 2025

Open Position

United Therapeutics is currently seeking a Associate Director, Organizational Resilience & Project Management. (California, Maryland, United States)

Dec 18 2024

Project

Pharmaceuticals, Clinical Operations, Corporate Strategy, Manufacturing Operations, Operations

Dec 18 2024

Project

plans to file an IND shortly for its 10-gene kidney xenotransplantation project, with FDA providing clarity on expectations. The company aims to move quickly into the first transplant after IND clearance, with the goal of long-term xenotransplants freeing patients from dialysis.

Engineering, Search, Bioengineering, Medical Research, Clinical Operations, Operations

Dec 18 2024

Project

United Therapeutics has reached a manufacturing capacity of 25,000 patient output for DPI, with plans to add 50,000 more by late 2027.

Capacity Planning, Facilities Management, Pharmaceuticals, Manufacturing Operations, Operations

Dec 18 2024

Project

Product Development, Product Management, Pharmaceuticals, Marketing Strategy

See more scoops

United Therapeutics News & Media

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its commercial and development portfolio in pulmonary hypertension (PH) will be presented at the Pulmonary Vascular Research Institute (PVRI) 2025 Annual Congress taking place January 29 through February 1, 2025 in Rio de Janeiro. In addition, professionals from United Therapeutics will participate in two speak
Jan 21, 2025
www.businesswire.com
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will provide an overview and update on the company’s business during a presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Monday, January 13, 2025, from 2:15 p.m. to 2:55 p.m., Pacific Standard Time,
Jan 6, 2025
www.businesswire.com
United Therapeutics Announces Successful World’s First UKidney Transplant
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)---- $UTHR #biotech--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world’s first transplant of a UKidney, which it produced, into a living person on November 25, 2024. The transplant is the fourth xenotransplant using United Therapeutics’ xeno organs into living humans, following two successful UHeart transplants at the University of Maryland Medicine in 2022 and 2023 and a succe
Dec 17, 2024
www.businesswire.com
Bank of Montreal Can Decreases Stake in United Therapeutics Co. (NASDAQ:UTHR)
Bank of Montreal Can decreased its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 11.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,013 shares of the biotechnology company's stock after s
Dec 1, 2024
www.marketbeat.com
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company’s operations during a fireside chat session at the UBS Global Healthcare Conference in Rancho Palos Verdes, CA. The session will take place on Tuesday, November 12, 2024, from 2:45 p.m. to 3:20 p.m., Pacific Standard
Nov 5, 2024
www.businesswire.com

Top Companies in United States

Frequently Asked Questions Regarding United Therapeutics

Where is United Therapeutics located?

United Therapeutics's headquarters are located at 1000 Spring St, Silver Spring, Maryland, 20910, United States

What is United Therapeutics's phone number?

United Therapeutics's phone number is (301) 608-9292

What is United Therapeutics's stock symbol?

United Therapeutics's stock symbol is UTHR

What is United Therapeutics's official website?

United Therapeutics's official website is www.unither.com

What is United Therapeutics's Revenue?

United Therapeutics's revenue is $2.8 Billion

What is United Therapeutics's SIC code?

United Therapeutics's SIC: 87,873

What is United Therapeutics's NAICS code?

United Therapeutics's NAICS: 54,541

How many employees does United Therapeutics have?

United Therapeutics has 1,168 employees

What industry does United Therapeutics belong to?

United Therapeutics is in the industry of: Business Services General, Business Services

What is United Therapeutics competition?

United Therapeutics top competitors include: Jazz Pharmaceuticals, BioMarin, EMD Serono, Neurocrine Biosciences

What companies has United Therapeutics acquired?

United Therapeutics has acquired the companies: SteadyMed

What technology does United Therapeutics use?

Some of the popular technologies that United Therapeutics uses are: Solidworks, Microsoft IIS, DocuSign, PHP

Who is the CFO of United Therapeutics?

United Therapeutics's CFO is James Edgemond

How do I contact United Therapeutics?

United Therapeutics contact info: Phone number: (301) 608-9292 Website: www.unither.com

What does United Therapeutics do?

What are United Therapeutics social media links?

United Therapeutics Linkedin page United Therapeutics Twitter page United Therapeutics Facebook page

How much funding has United Therapeutics raised to date?

United Therapeutics has raised $54 Million in 1 funding round

When was the last funding round for United Therapeutics?

United Therapeutics closed its last funding round on Jun 16, 1999 with the amount of $54 Million

Is United Therapeutics a public company?

Yes, United Therapeutics is a public company and is traded under the symbol UTHR

See more information about United Therapeutics

United Therapeutics Latest Hires and Their Positions

United Therapeutics is expanding and recently hired new employees. Here are the latest additions to the team.

William Sirls

Calibration Technician II

Joined Jan 4, 2025

Phone

Rachel McNeill

Animal Care Supervisor

Joined Jan 4, 2025

Phone

Melissa Bethea

Senior Global Gxp Document QC Specialist

Joined Jan 4, 2025

Phone

Nosa Owens

Tableau Strategic Operations Administrator

Joined Jan 4, 2025

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.